English
Home > Products > 30389-25-4

China 30389-25-4 Factory

It is a great way to further improve our products and repair. Our mission is always to create innovative products to prospects with a superior expertise for 30389-25-4,CAS NO 30389-25-4,(Perfluorodecyl)ethylene, Adhering on the company principle of mutual gains, we have won superior popularity amid our shoppers because of our excellent products and services, excellent products and aggressive selling prices. We warmly welcome shoppers from home and overseas to cooperate with us for common achievements.
30389-25-4, Our company is working by the operation principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we can have a friendly relationship with businessman from all over the world.

Related Products

Hot Products

  • L-Phenylalanine

    L-Phenylalanine

    Product Name:L-Phenylalanine
    Molecular Formula:C9H11NO2
    Molecular Weight;165.19
    CAS Registry Number;63-91-2
  • Prilocaine

    Prilocaine

    Product Name:Prilocaine
    Molecular Formula:C13H20N2O
    Molecular Weight;220.31
    CAS Registry Number;721-50-6
  • Aprepitant

    Aprepitant

    Product Name:Aprepitant
    Molecular Formula:C23H21F7N4O3
    Molecular Weight;534.43
    CAS Registry Number;170729-80-3
  • BenzeneMethanol, 4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]- (hydrochloride)

    BenzeneMethanol, 4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]- (hydrochloride)

    Product Name:BenzeneMethanol, 4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]- (hydrochloride)
    Molecular Formula:C15H24ClNO2
    Molecular Weight:285.81
    CAS Registry Number:328933-65-9
  • 4-Bromo-2-fluorotoluene

    4-Bromo-2-fluorotoluene

    Product Name:4-Bromo-2-fluorotoluene
    Molecular Formula:C7H6BrF
    Molecular Weight:189.02
    CAS Registry Number:51436-99-8
  • N-Benzyloxycarbonyl-L-proline

    N-Benzyloxycarbonyl-L-proline

    Product Name:N-Benzyloxycarbonyl-L-proline
    Molecular Formula:C13H15NO4
    Molecular Weight:249.26
    CAS Registry Number:1148-11-4
  • Related Blog
  • Reviews

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Related Search

CAS NO 30389-25-4

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept